knowledge -WSS

knowledge

author：leisure time 2025-08-26 23:48:05 - browse：3

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

WSS

My yearlong odyssey to get my son’s ADHD medication covered

Readout Newsletter: Merck, J&J, and long Covid

Eli Lilly, Pfizer, and others want in on the online prescription market

The tragedy of Johnson & Johnson’s Covid vaccine

Doctors increasingly discourage vaping amid mounting health concerns

Copay coupons to count toward deductibles, after Biden court move

knowledge

knowledge

knowledge

Walensky prepares to leave CDC — and Congress — behind

Prior authorization will have to move faster under new Biden rule

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

BioMarin wins approval for gene therapy to treat hemophilia A

New brain studies show LSD's effects on the brain in full color

Alkermes shareholders re

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

In age of alternative facts, a scholarly course on calling out crap

American TikTok star stuck in Dubai for months following rental car altercation

focus

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

'Weather

Parkinson’s finding may lead to tests and, someday, treatments

'Weather

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Eli Lilly, Pfizer, and others want in on the online prescription market

entertainment

hotspot

Wikipedia

focus